top of page

Achieved 13% cost reduction in major Generics & Biosimilar production site through inclusive ideation & robust structured approach

Pharma Manufacturing
Efficiency Program
Efficiency Program
Client Context And Challenges
  • Generics and Biosimilar arm of a global pharmaceutical player has been running an efficiency program globally for a few years but struggled to make significant progress in one of their biggest sites in Europe.

  • The client decided to bring in external support to provide more transparency to the local situation and to create an efficiency program with recurring cost savings targets

  • We were selected due to our experience in life sciences and our ability to work hand-in-hand with clients in an operational setting

Our Approach
  • Transparency: Established a clear cost baseline that is easy to compare across sites and within industry. Pulled together a prioritised set of areas to focus on.

  • Involvement: Set-up a series of working sessions for each critical business unit and also across business units to collectively identify savings opportunities, conditions required for sustained impact and implementation requirements

  • Ownership: Established a program where each efficiency idea was owned by a leader on site and supported by us

  • Impact: Built a business case for each efficiency initiative with full financial impact

Tracking: Built a robust tracking methodology that was handed over to the client for all future efficiency efforts

Impact We Achieved
  • Generated more than 120 efficiency opportunities with wide-range involvements from employees on site

  • Prioritised for impact and ease of implementation & short-listed 18 for full business case

  • Achieved 13% reduction in baseline cost-base; and realised 6% within the year

bottom of page